Published in Mol Cancer on July 19, 2006
MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA (2008) 12.26
OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer (2007) 4.59
MicroRNAs in cancer. Annu Rev Pathol (2009) 4.47
A transposon-based genetic screen in mice identifies genes altered in colorectal cancer. Science (2009) 4.16
Real-time PCR quantification of precursor and mature microRNA. Methods (2008) 4.12
Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem (2009) 3.89
miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors. Mol Cell (2010) 3.27
The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts. Cell Cycle (2010) 2.69
Distinct microRNA alterations characterize high- and low-grade bladder cancer. Cancer Res (2009) 2.58
The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chromosomes Cancer (2008) 2.52
miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer (2010) 2.51
MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer (2009) 2.45
CRD-BP protects the coding region of betaTrCP1 mRNA from miR-183-mediated degradation. Mol Cell (2009) 2.38
Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene (2007) 2.36
Prognostic Values of microRNAs in Colorectal Cancer. Biomark Insights (2006) 2.35
Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer (2009) 2.32
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer (2009) 2.27
The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Br J Cancer (2011) 2.25
Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types. PLoS One (2009) 2.21
MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer. BMC Cancer (2010) 2.10
miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells. J Biol Chem (2010) 2.05
Modulation of mismatch repair and genomic stability by miR-155. Proc Natl Acad Sci U S A (2010) 2.05
Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention. Int J Mol Sci (2013) 2.00
Disruption of microRNA expression in human airway cells by diesel exhaust particles is linked to tumorigenesis-associated pathways. Environ Health Perspect (2009) 1.98
Environmental chemical exposures and human epigenetics. Int J Epidemiol (2011) 1.97
MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines. Cancer Lett (2009) 1.92
MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer (2009) 1.88
MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression. Br J Cancer (2009) 1.87
MicroRNAs in tumorigenesis: a primer. Am J Pathol (2007) 1.83
microRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers. Oncotarget (2012) 1.83
MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis. Nucleic Acids Res (2011) 1.77
MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1. Nat Commun (2013) 1.76
MicroRNAs as potential biomarkers in human solid tumors. Cancer Lett (2012) 1.73
Down-regulation of miR-141 in gastric cancer and its involvement in cell growth. J Gastroenterol (2009) 1.73
Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancer. Br J Cancer (2011) 1.73
miRNA expression in colon polyps provides evidence for a multihit model of colon cancer. PLoS One (2011) 1.72
MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines. PLoS One (2009) 1.70
MicroRNA profiling and head and neck cancer. Comp Funct Genomics (2009) 1.68
The nuclear envelope environment and its cancer connections. Nat Rev Cancer (2012) 1.68
Altered retinal microRNA expression profile in a mouse model of retinitis pigmentosa. Genome Biol (2007) 1.67
MicroRNA-145 targets YES and STAT1 in colon cancer cells. PLoS One (2010) 1.64
MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice. Alcohol Clin Exp Res (2009) 1.61
A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells. Cancer Biol Ther (2009) 1.61
Epigenetics of colorectal cancer. Gastroenterology (2012) 1.60
Regulation of ABCG2 expression at the 3' untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line. Mol Cell Biol (2008) 1.58
Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing. PLoS One (2012) 1.58
MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. Biochem Biophys Res Commun (2009) 1.58
Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease. PLoS One (2010) 1.54
Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a. PLoS One (2010) 1.49
The silkworm (Bombyx mori) microRNAs and their expressions in multiple developmental stages. PLoS One (2008) 1.48
Advances in the genetics of glioblastoma: are we reaching critical mass? Nat Rev Neurol (2009) 1.48
Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. J Mol Diagn (2010) 1.47
miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer. PLoS One (2015) 1.46
Dysregulated miR-183 inhibits migration in breast cancer cells. BMC Cancer (2010) 1.46
An essential mesenchymal function for miR-143/145 in intestinal epithelial regeneration. Cell (2014) 1.44
MicroRNA signature analysis in colorectal cancer: identification of expression profiles in stage II tumors associated with aggressive disease. Int J Colorectal Dis (2011) 1.43
microRNAs: a new emerging class of players for disease diagnostics and gene therapy. J Cell Mol Med (2007) 1.43
miR-Q: a novel quantitative RT-PCR approach for the expression profiling of small RNA molecules such as miRNAs in a complex sample. BMC Mol Biol (2008) 1.42
An evaluation and replication of miRNAs with disease stage and colorectal cancer-specific mortality. Int J Cancer (2014) 1.42
n-3 Polyunsaturated fatty acids modulate carcinogen-directed non-coding microRNA signatures in rat colon. Carcinogenesis (2009) 1.41
A computational screen for mouse signaling pathways targeted by microRNA clusters. RNA (2008) 1.41
MicroRNA and colorectal cancer. World J Surg (2009) 1.40
The clinical potential of microRNAs. J Hematol Oncol (2010) 1.39
Effect of ret/PTC 1 rearrangement on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model. Mol Cancer (2006) 1.37
Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma. Oncotarget (2012) 1.36
Identification and functional screening of microRNAs highly deregulated in colorectal cancer. J Cell Mol Med (2012) 1.34
Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: a case control study. BMC Cancer (2011) 1.34
Epigenetics and colorectal cancer pathogenesis. Cancers (Basel) (2013) 1.33
Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation. Inflamm Bowel Dis (2011) 1.33
Expression profiling of microRNA using oligo DNA arrays. Methods (2008) 1.31
Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer. BMC Cancer (2012) 1.30
MicroRNA-mediated control in the skin. Cell Death Differ (2009) 1.30
MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma. PLoS One (2010) 1.30
Pre-microRNA and mature microRNA in human mitochondria. PLoS One (2011) 1.29
Non-coding RNAs: a key to future personalized molecular therapy? Genome Med (2010) 1.29
miR-145-mediated suppression of cell growth, invasion and metastasis. Am J Transl Res (2010) 1.29
Targeting of integrin beta1 and kinesin 2alpha by microRNA 183. J Biol Chem (2009) 1.28
Discovery of microRNAs and other small RNAs in solid tumors. Nucleic Acids Res (2010) 1.28
Colorectal cancers with microsatellite instability display unique miRNA profiles. Clin Cancer Res (2011) 1.27
The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer. PLoS One (2012) 1.26
MicroRNAs: tools for cancer diagnostics. Gut (2009) 1.25
MicroRNAs as biomarkers in colorectal cancer. Am J Pathol (2010) 1.25
Deep Sequencing the MicroRNA Transcriptome in Colorectal Cancer. PLoS One (2013) 1.22
Gliomas display a microRNA expression profile reminiscent of neural precursor cells. Neuro Oncol (2010) 1.22
MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas. J Oral Maxillofac Res (2013) 1.22
The oncogenic role of microRNA-130a/301a/454 in human colorectal cancer via targeting Smad4 expression. PLoS One (2013) 1.22
Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer. Oncol Lett (2012) 1.21
MicroRNA dysregulation in colorectal cancer: a clinical perspective. Br J Cancer (2011) 1.20
Suppression of microRNA-31 increases sensitivity to 5-FU at an early stage, and affects cell migration and invasion in HCT-116 colon cancer cells. BMC Cancer (2010) 1.20
The impact of microRNAs on colorectal cancer. Virchows Arch (2009) 1.20
MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma. Cancer Lett (2013) 1.19
MicroRNA-145 in vascular smooth muscle cell biology: a new therapeutic target for vascular disease. Cell Cycle (2009) 1.19
Alterations of microRNAs contribute to colon carcinogenesis. Semin Oncol (2011) 1.19
EGFR signals downregulate tumor suppressors miR-143 and miR-145 in Western diet-promoted murine colon cancer: role of G1 regulators. Mol Cancer Res (2011) 1.18
Dissecting microregulation of a master regulatory network. BMC Genomics (2008) 1.18
MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary. PLoS One (2009) 1.18
miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer. Cell Death Dis (2013) 1.16
Differential expression of microRNAs in tumors from chronically inflamed or genetic (APC(Min/+)) models of colon cancer. PLoS One (2011) 1.16
MicroRNA-31 regulated by the extracellular regulated kinase is involved in vascular smooth muscle cell growth via large tumor suppressor homolog 2. J Biol Chem (2011) 1.16
MiR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation, migration and invasion, and promotes apoptosis. PLoS One (2013) 1.15
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
MicroRNA expression profiles classify human cancers. Nature (2005) 69.12
Mutations of the BRAF gene in human cancer. Nature (2002) 65.42
The functions of animal microRNAs. Nature (2004) 64.85
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature (2005) 48.95
Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer (2006) 46.47
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A (2006) 40.09
MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet (2004) 37.83
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (2002) 32.26
c-Myc-regulated microRNAs modulate E2F1 expression. Nature (2005) 31.81
RAS is regulated by the let-7 microRNA family. Cell (2005) 30.24
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res (2005) 29.17
MicroRNA gene expression deregulation in human breast cancer. Cancer Res (2005) 27.56
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell (2006) 23.59
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res (2005) 18.58
Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res (2003) 17.13
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci U S A (2004) 13.66
The colorectal microRNAome. Proc Natl Acad Sci U S A (2006) 11.59
A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell (2006) 11.01
A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res (2005) 10.46
The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A (2005) 8.60
Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell (2004) 8.16
Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene (2006) 6.61
Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem J (2000) 6.55
A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain. Genome Res (2004) 5.77
Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. J Natl Cancer Inst (2003) 5.64
How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev (2005) 5.22
Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Res (2002) 4.46
Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res (2006) 3.32
Quantitation of microRNAs using a modified Invader assay. RNA (2004) 3.12
Mutational analysis of BRAF and K-ras in gastric cancers: absence of BRAF mutations in gastric cancers. Hum Genet (2003) 1.21
Association of Escherichia coli HEp-2 adherence patterns with type and duration of diarrhoea. Lancet (1991) 4.52
Signatures of positive selection in genes associated with human skin pigmentation as revealed from analyses of single nucleotide polymorphisms. Ann Hum Genet (2007) 4.21
High rate of inbreeding in Spanish universities. Nature (2001) 3.48
Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene (2009) 3.09
The estimation of the number and the length distribution of gene conversion tracts from population DNA sequence data. Genetics (1997) 2.11
Inversion polymorphisms and nucleotide variability in Drosophila. Genet Res (2001) 2.00
Genetic diversity and population structure of Vibrio cholerae. J Clin Microbiol (1999) 2.00
Polymorphisms of the repeated sequences in the enhancer region of the thymidylate synthase gene promoter may predict downstaging after preoperative chemoradiation in rectal cancer. J Clin Oncol (2001) 1.98
Risk of diarrhea during the first year of life associated with initial and subsequent colonization by specific enteropathogens. Am J Epidemiol (1990) 1.95
Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer. Clin Transl Oncol (2012) 1.80
Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer. Gastroenterology (1998) 1.69
Quality of life during chemotherapy in non-small cell lung cancer patients. Acta Oncol (1989) 1.68
International development of the Quality of Life in Depression Scale (QLDS). J Affect Disord (2001) 1.58
Specific small nucleolar RNA expression profiles in acute leukemia. Leukemia (2012) 1.56
Acute appendicitis in an incarcerated crural hernia: analysis of our experience. Rev Esp Enferm Dig (2005) 1.49
Etiology of solitary pulmonary nodules in patients with human immunodeficiency virus infection. Clin Infect Dis (1997) 1.48
Complex high-resolution linkage disequilibrium and haplotype patterns of single-nucleotide polymorphisms in 2.5 Mb of sequence on human chromosome 21. Genomics (2001) 1.47
Effectiveness of continuous positive airway pressure in mild sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med (2001) 1.43
Comparison of the analgesic effects of meloxicam and carprofen administered preoperatively to dogs undergoing orthopaedic surgery. Vet Rec (2004) 1.42
NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome. Leukemia (2012) 1.41
Growth and growth hormone secretion in children with cancer treated with chemotherapy. J Pediatr (1997) 1.41
Sequence family variant loss from the AZFc interval of the human Y chromosome, but not gene copy loss, is strongly associated with male infertility. J Med Genet (2004) 1.40
[Mortality following cardiac surgery in the National Health Service Hospitals of the Community of Valencia in 2007: a descriptive analysis]. Rev Esp Anestesiol Reanim (2010) 1.40
Genetic association of CASP8 polymorphisms with primary progressive multiple sclerosis. J Neuroimmunol (2010) 1.40
Effectiveness of TLSO bracing in the conservative treatment of idiopathic scoliosis. J Pediatr Orthop (1995) 1.40
The serological assessment of a tetanus toxoid field trial. Bull World Health Organ (1971) 1.40
[Effectiveness of a mandibular advancement prosthesis in the treatment of obstructive sleep apnea syndrome]. Arch Bronconeumol (2000) 1.39
[Significance of heterozygosity loss in the long arm of chromosome 5 (5q21) in small cell carcinoma of the lung]. Med Clin (Barc) (1997) 1.39
[HELLP syndrome]. Med Clin (Barc) (2001) 1.39
Interrelationship of capsule thickness and breast hardness confirmed by a new measurement method. Plast Reconstr Surg (1991) 1.39
[Benign amaurosis fugax]. Neurologia (1993) 1.39
Trapezius transfer for shoulder paralysis. 6 patients with brachial plexus injuries followed for 1 year. Acta Orthop Scand (1998) 1.38
Two beta-glycanase genes are clustered in Bacillus polymyxa: molecular cloning, expression, and sequence analysis of genes encoding a xylanase and an endo-beta-(1,3)-(1,4)-glucanase. J Bacteriol (1991) 1.37
Regulatory behavior of monomeric enzymes. 2. A wheat-germ hexokinase as a mnemonical enzyme. Eur J Biochem (1974) 1.27
Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype. Breast Cancer Res Treat (1999) 1.22
Downregulation of the large tumor suppressor 2 (LATS2/KPM) gene is associated with poor prognosis in acute lymphoblastic leukemia. Leukemia (2005) 1.19
Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease. Leukemia (2012) 1.17
Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia. J Antimicrob Chemother (2000) 1.15
MEFV mutations in Behçet's disease. Hum Mutat (2000) 1.13
Is a general women's health promotion program as effective as an HIV-intensive prevention program in reducing HIV risk among Hispanic women? Public Health Rep (2002) 1.12
Transcriptional silencing of the Dickkopfs-3 (Dkk-3) gene by CpG hypermethylation in acute lymphoblastic leukaemia. Br J Cancer (2004) 1.11
Sulbactam efficacy in experimental models caused by susceptible and intermediate Acinetobacter baumannii strains. J Antimicrob Chemother (2001) 1.10
Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients. Eur J Cancer (2009) 1.08
On the fertility effects of pericentric inversions. Genetics (1997) 1.07
Hydroxyapatite-coated external-fixation pins. The effect on pin loosening and pin-track infection in leg lengthening for short stature. J Bone Joint Surg Br (2004) 1.07
Molecular staging of non-small cell lung cancer according to K-ras genotypes. Clin Cancer Res (1996) 1.05
Primary structure of an agonist binding subunit of the nicotinic acetylcholine receptor from bovine adrenal chromaffin cells. Neurochem Res (1992) 1.04
Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas. Leukemia (2011) 1.04
Association of HLA-DR4-Dw15 (DRB1*0405) and DR10 with rheumatoid arthritis in a Spanish population. Arthritis Rheum (1993) 1.01
Community-acquired febrile urinary tract infection in diabetics could deserve a different management: a case-control study. J Intern Med (2003) 1.01
Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine. Lung Cancer (2011) 1.01
Riboprinting and 16S rRNA gene sequencing for identification of brewery Pediococcus isolates. Appl Environ Microbiol (2001) 1.00
Mutated K-ras gene analysis in a randomized trial of preoperative chemotherapy plus surgery versus surgery in stage IIIA non-small cell lung cancer. Lung Cancer (1995) 1.00
Delayed papillary muscle rupture following mild chest trauma. J Heart Valve Dis (1995) 1.00
Evaluation of transplant procurement management courses: an educational project as a tool for the optimization of transplant coordination. Transplant Proc (2003) 0.99
Design and validation of a specialized training model for tissue bank personnel as a result of the European Quality System for Tissue Banking (EQSTB) project. Transplant Proc (2007) 0.98
Bortezomib decreases Rb phosphorylation and induces caspase-dependent apoptosis in Imatinib-sensitive and -resistant Bcr-Abl1-expressing cells. Oncogene (2010) 0.98
Interphotoreceptor retinoid-binding protein (IRBP) is downregulated at early stages of diabetic retinopathy. Diabetologia (2009) 0.97
Association between bone mineral density and polymorphisms of the VDR, ERalpha, COL1A1 and CTR genes in Spanish postmenopausal women. J Endocrinol Invest (2005) 0.97
Normothermic recirculation reduces primary graft dysfunction of kidneys obtained from non-heart-beating donors. Transpl Int (2000) 0.97
The Girdlestone pseudarthrosis in the treatment of infected hip replacements. Int Orthop (1998) 0.97
Acute myeloid leukemia with translocation (8;16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene. Leukemia (2012) 0.96
Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis. Br J Cancer (2010) 0.96
Oxidative stress-induced glucocorticoid resistance is prevented by dual PDE3/PDE4 inhibition in human alveolar macrophages. Clin Exp Allergy (2011) 0.95
Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer. Gynecol Oncol (1999) 0.95
Instrumentation and calibration protocol for imaging dynamic features in dense-scattering media by optical tomography. Appl Opt (2000) 0.95
Non-cystic fibrosis bronchiectasis in childhood: longitudinal growth and lung function. Thorax (2008) 0.95
DUSP1/MKP1 promotes angiogenesis, invasion and metastasis in non-small-cell lung cancer. Oncogene (2010) 0.94
Comparative pollination biology of Venezuelan columnar cacti and the role of nectar-feeding bats in their sexual reproduction. Am J Bot (1997) 0.94
Lack of cross-species transmission of porcine endogenous retrovirus infection to nonhuman primate recipients of porcine cells, tissues, or organs. Transplantation (2001) 0.94
Detection of chromosome 3p alterations in serum DNA of non-small-cell lung cancer patients. Ann Oncol (1998) 0.93
Rapid quantitative detection of BCR-ABL transcripts in chronic myeloid leukemia patients by real-time reverse transcriptase polymerase-chain reaction using fluorescently labeled probes. Haematologica (2000) 0.93
Epidermal growth factor receptor inhibitors in colorectal cancer treatment: what's new? World J Gastroenterol (2007) 0.93
The human Y chromosome genes BPY2, CDY1 and DAZ are not essential for sustained fertility. Mol Hum Reprod (2000) 0.93
Genetic diversity of indigenous rhizobial symbionts of the Lupinus mariae-josephae endemism from alkaline-limed soils within its area of distribution in Eastern Spain. Syst Appl Microbiol (2013) 0.92
Persistence of intracranial diastolic flow in transcranial Doppler sonography exploration of patients in brain death. Transplant Proc (2003) 0.92
The elements of the locus of enterocyte effacement in human and wild mammal isolates of Escherichia coli: evolution by assemblage or disruption? Microbiology (2001) 0.92
Alpha-MSH regulates interleukin-10 expression by human keratinocytes. Arch Dermatol Res (1998) 0.92
HLA-DRw10 confers the highest susceptibility to rheumatoid arthritis in a Spanish population. Tissue Antigens (1990) 0.92
Structure of linkage disequilibrium in humans: genome factors and population stratification. Cold Spring Harb Symp Quant Biol (2003) 0.91
Case-control study of risk factors for the development of enterococcal bacteremia. Eur J Clin Microbiol Infect Dis (2001) 0.90
Agrobacterium-mediated transformation of sweet orange and regeneration of transgenic plants. Plant Cell Rep (1995) 0.90
Chromosomal evolution: inversions: the chicken or the egg? Heredity (Edinb) (2007) 0.90
Reduced survival in patients with stage-I non-small-cell lung cancer associated with DNA-replication errors. Int J Cancer (1997) 0.90
Auditory event-related potentials in 50 melancholic patients: increased N100, N200 and P300 latencies and diminished P300 amplitude. J Affect Disord (2003) 0.90
Genomic variability of Haemophilus influenzae isolated from Mexican children determined by using enterobacterial repetitive intergenic consensus sequences and PCR. J Clin Microbiol (2000) 0.90
Prognostic value of K-ras mutations and allelic imbalance on chromosome 18q in patients with resected colorectal cancer. Dis Colon Rectum (2001) 0.90
Promoter hypermethylation and global hypomethylation are independent epigenetic events in lymphoid leukemogenesis with opposing effects on clinical outcome. Leukemia (2006) 0.89
Allergen-specific nasal provocation testing: review by the rhinoconjunctivitis committee of the Spanish Society of Allergy and Clinical Immunology. J Investig Allergol Clin Immunol (2011) 0.89
Lipase-catalyzed synthesis of xylitol monoesters: solvent engineering approach. J Biotechnol (2003) 0.88
Occurrence of Neospora caninum and Toxoplasma gondii infections in ovine and caprine abortions. Vet Parasitol (2012) 0.88
Microsatellite instability and p53 mutations in sporadic right and left colon carcinoma: different clinical and molecular implications. Cancer (1998) 0.88